Milbemax film coated tablets for small cats and kittens
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
05-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
milbemycin oxime praziquantel
Available from:
Novartis Animal Health UK Ltd
ATC code:
QP54AB51
Dosage:
Unknown
Pharmaceutical form:
Coated Tablets
Therapeutic group:
Feline
Therapeutic area:
Endoparasiticide
Authorization status:
Authorised
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Milbemax Film-coated tablets for small cats and kittens
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Excipients QS one divisible tablet of 132.5 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Film-coated tablet
Oblong shaped, beige to brown, artificial beef flavoured tablet with a score on both sides.
One side bears the imprint “BC”, the other side “NA”.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cats: treatment of mixed infections by immature and adult cestodes AND nematodes of the following species :
- Cestodes:
_Dipylidium caninum_
_Taenia spp._
_Echinococcus multilocularis_
- Nematodes:
_Ancylostoma tubaeforme_
_Toxocara cati_
Prevention of heartworm disease (Dirofilaria immitis) if concomitant treatment against cestodes is indicated.
Each tablet contains:
Active substances:
Milbemycin oxime
4 mg
Praziquantel
10 mg
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 27/03/2014_
_CRN 7017150_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use in cats of less than 6 weeks of age and/or weighing less than 0.5 kg.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
As per good veterinary practice, animals should be weighed to ensure accurate dosing.
Echinococcosis represents a hazard for humans. In case of Echinococcosis, specific guidelines on the treatment and
follow up and on the safeguard of persons have to be followed. Experts or institutes of parasitology should be
consulted.
No studies have been performed with severely debilitated cats or individuals with seriously
Read the complete document
